Follicular low-grade non-Hodgkin's lymphoma: Long term outcome with or without tumor progression
J. Ersboll H.B. Schultz D. Pedersen-Bjergaard et al. Follicular low-grade non-Hodgkin's lymphoma: Long term outcome with or without tumor progression Eur J Haematol 42c 1989 155-163
High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial
H.C. Schouten W. Qian S. Kvaloy et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial J Clin Oncol 21 2003 3918-3927
National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma: Summary and description of working formulation for clinical usage
National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma: Summary and description of working formulation for clinical usage Cancer 49 1982 2112-2135
Autologous bone marrow transplantation in non-Hodgkin's lymphomas. Monoclonal antibodies plus complement for ex vivo treatment
D.D. Hurd T.W. Le Bien L.C. Alsky et al. Autologous bone marrow transplantation in non-Hodgkin's lymphomas. Monoclonal antibodies plus complement for ex vivo treatment Am J Med 85 1988 829-834
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma
A.Z. Rohatiner P.W. Johnson C.G. Price et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma J Clin Oncol 12 1994 1177-1184
Low-grade stage III-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients - A study of the groupe d'Etude des lymphomes de l'Adulte
D. Decaudin E. Lepage N. Brousse et al. Low-grade stage III-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients - a study of the groupe d'Etude des lymphomes de l'Adulte J Clin Oncol 17 1999 2499-2505
Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors
S. Montoto A. Lopez-Guillermo A. Ferrer et al. Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors Ann Oncol 13 2002 523-530
High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre
J.M. Foran J. Apostolidis D. Papamichael et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre Ann Oncol 9 1998 865-869
Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma
L.B. Travis J. Weeks R.E. Curtis et al. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma J Clin Oncol 14 1996 565-571
Incidence and characterization of secondary myelodysplastic syndromes and acute myelogenous leukemia following high dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies
S.L. Darrington J.M. Vose J.R. Anderson et al. Incidence and characterization of secondary myelodysplastic syndromes and acute myelogenous leukemia following high dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies J Clin Oncol 12 1994 2527-2534
A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma
The Non-Hodgkin's Lymphoma Classification Project
The Non-Hodgkin's Lymphoma Classification Project A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma Blood 89 1997 3909-3918